(Adds details throughout)
June 3 (Reuters) - Illumina ILMN.O , a maker of gene
sequencing machines, said on Monday it expected to spin off
cancer test maker Grail GRAL.O .
On June 24, shareholders of Illumina will receive one share
of Grail common stock for every six shares of Illumina common
stock held at the close of business on June 13, 2024.
Illumina said it would retain a 14.5% stake in Grail.
(Reporting by Puyaan Singh in Bengaluru; Editing by Anil
D'Silva)
((Puyaan.Singh@thomsonreuters.com;))